Table of Content

1 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Overview
1.1 Product Overview and Scope of Kidney Injury Molecule 1 (KIM-1) ELISA Kit
1.2 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Segment by Type
1.2.1 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Value Comparison by Type (2024-2034)
1.2.2 Human
1.2.3 Mouse
1.2.4 Rat
1.2.5 Porcine
1.2.6 Others
1.3 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Segment by Application
1.3.1 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Research Institute
1.3.4 Others
1.4 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Size Estimates and Forecasts
1.4.1 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue 2018-2029
1.4.2 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales 2018-2029
1.4.3 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Competition by Manufacturers
2.1 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Market Share by Manufacturers (2018-2024)
2.2 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Average Price by Manufacturers (2018-2024)
2.4 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Kidney Injury Molecule 1 (KIM-1) ELISA Kit, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Kidney Injury Molecule 1 (KIM-1) ELISA Kit, Product Type & Application
2.7 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Competitive Situation and Trends
2.7.1 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Kidney Injury Molecule 1 (KIM-1) ELISA Kit Players Market Share by Revenue
2.7.3 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Retrospective Market Scenario by Region
3.1 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Region: 2018-2029
3.2.1 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Region: 2018-2024
3.2.2 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Region: 2024-2029
3.3 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Region: 2018-2029
3.3.1 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Region: 2018-2024
3.3.2 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Region: 2024-2029
3.4 North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Facts & Figures by Country
3.4.1 North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Country (2018-2029)
3.4.3 North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Facts & Figures by Country
3.5.1 Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Country (2018-2029)
3.5.3 Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Facts & Figures by Country
3.6.1 Asia Pacific Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Country (2018-2029)
3.6.3 Asia Pacific Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Facts & Figures by Country
3.7.1 Latin America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Country (2018-2029)
3.7.3 Latin America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Facts & Figures by Country
3.8.1 Middle East and Africa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Country (2018-2029)
3.8.3 Middle East and Africa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Type (2018-2029)
4.1.1 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Type (2018-2024)
4.1.2 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Type (2024-2029)
4.1.3 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Market Share by Type (2018-2029)
4.2 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Type (2018-2029)
4.2.1 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Type (2018-2024)
4.2.2 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Type (2024-2029)
4.2.3 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Market Share by Type (2018-2029)
4.3 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Price by Type (2018-2029)
5 Segment by Application
5.1 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Application (2018-2029)
5.1.1 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Application (2018-2024)
5.1.2 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Application (2024-2029)
5.1.3 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Market Share by Application (2018-2029)
5.2 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Application (2018-2029)
5.2.1 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Application (2018-2024)
5.2.2 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Application (2024-2029)
5.2.3 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Market Share by Application (2018-2029)
5.3 Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Elabscience Biotechnology Inc.
6.1.1 Elabscience Biotechnology Inc. Corporation Information
6.1.2 Elabscience Biotechnology Inc. Description and Business Overview
6.1.3 Elabscience Biotechnology Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Elabscience Biotechnology Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Portfolio
6.1.5 Elabscience Biotechnology Inc. Recent Developments/Updates
6.2 Crystal Chem
6.2.1 Crystal Chem Corporation Information
6.2.2 Crystal Chem Description and Business Overview
6.2.3 Crystal Chem Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Crystal Chem Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Portfolio
6.2.5 Crystal Chem Recent Developments/Updates
6.3 Wuhan Fine Biotech Co., Ltd.
6.3.1 Wuhan Fine Biotech Co., Ltd. Corporation Information
6.3.2 Wuhan Fine Biotech Co., Ltd. Description and Business Overview
6.3.3 Wuhan Fine Biotech Co., Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Wuhan Fine Biotech Co., Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Portfolio
6.3.5 Wuhan Fine Biotech Co., Ltd. Recent Developments/Updates
6.4 MyBiosource, Inc.
6.4.1 MyBiosource, Inc. Corporation Information
6.4.2 MyBiosource, Inc. Description and Business Overview
6.4.3 MyBiosource, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.4.4 MyBiosource, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Portfolio
6.4.5 MyBiosource, Inc. Recent Developments/Updates
6.5 Shanghai Korain Biotech Co., Ltd.
6.5.1 Shanghai Korain Biotech Co., Ltd. Corporation Information
6.5.2 Shanghai Korain Biotech Co., Ltd. Description and Business Overview
6.5.3 Shanghai Korain Biotech Co., Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Shanghai Korain Biotech Co., Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Portfolio
6.5.5 Shanghai Korain Biotech Co., Ltd. Recent Developments/Updates
6.6 Abcam
6.6.1 Abcam Corporation Information
6.6.2 Abcam Description and Business Overview
6.6.3 Abcam Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Abcam Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Portfolio
6.6.5 Abcam Recent Developments/Updates
6.7 Enzo Life Sciences, Inc.
6.6.1 Enzo Life Sciences, Inc. Corporation Information
6.6.2 Enzo Life Sciences, Inc. Description and Business Overview
6.6.3 Enzo Life Sciences, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Enzo Life Sciences, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Portfolio
6.7.5 Enzo Life Sciences, Inc. Recent Developments/Updates
6.8 CUSABIO
6.8.1 CUSABIO Corporation Information
6.8.2 CUSABIO Description and Business Overview
6.8.3 CUSABIO Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.8.4 CUSABIO Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Portfolio
6.8.5 CUSABIO Recent Developments/Updates
6.9 CLOUD-CLONE CORP.
6.9.1 CLOUD-CLONE CORP. Corporation Information
6.9.2 CLOUD-CLONE CORP. Description and Business Overview
6.9.3 CLOUD-CLONE CORP. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.9.4 CLOUD-CLONE CORP. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Portfolio
6.9.5 CLOUD-CLONE CORP. Recent Developments/Updates
6.10 Creative Diagnostics
6.10.1 Creative Diagnostics Corporation Information
6.10.2 Creative Diagnostics Description and Business Overview
6.10.3 Creative Diagnostics Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Creative Diagnostics Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Portfolio
6.10.5 Creative Diagnostics Recent Developments/Updates
6.11 Bio-Techne
6.11.1 Bio-Techne Corporation Information
6.11.2 Bio-Techne Kidney Injury Molecule 1 (KIM-1) ELISA Kit Description and Business Overview
6.11.3 Bio-Techne Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Bio-Techne Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Portfolio
6.11.5 Bio-Techne Recent Developments/Updates
6.12 Innovative Research
6.12.1 Innovative Research Corporation Information
6.12.2 Innovative Research Kidney Injury Molecule 1 (KIM-1) ELISA Kit Description and Business Overview
6.12.3 Innovative Research Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Innovative Research Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Portfolio
6.12.5 Innovative Research Recent Developments/Updates
6.13 RayBiotech, Inc.
6.13.1 RayBiotech, Inc. Corporation Information
6.13.2 RayBiotech, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Description and Business Overview
6.13.3 RayBiotech, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.13.4 RayBiotech, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Portfolio
6.13.5 RayBiotech, Inc. Recent Developments/Updates
6.14 Assay Genie
6.14.1 Assay Genie Corporation Information
6.14.2 Assay Genie Kidney Injury Molecule 1 (KIM-1) ELISA Kit Description and Business Overview
6.14.3 Assay Genie Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Assay Genie Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Portfolio
6.14.5 Assay Genie Recent Developments/Updates
6.15 Cepham Life Sciences, Inc
6.15.1 Cepham Life Sciences, Inc Corporation Information
6.15.2 Cepham Life Sciences, Inc Kidney Injury Molecule 1 (KIM-1) ELISA Kit Description and Business Overview
6.15.3 Cepham Life Sciences, Inc Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Cepham Life Sciences, Inc Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Portfolio
6.15.5 Cepham Life Sciences, Inc Recent Developments/Updates
6.16 Abbexa
6.16.1 Abbexa Corporation Information
6.16.2 Abbexa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Description and Business Overview
6.16.3 Abbexa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Abbexa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Portfolio
6.16.5 Abbexa Recent Developments/Updates
6.17 Geno Technology, Inc.
6.17.1 Geno Technology, Inc. Corporation Information
6.17.2 Geno Technology, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Description and Business Overview
6.17.3 Geno Technology, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Geno Technology, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Portfolio
6.17.5 Geno Technology, Inc. Recent Developments/Updates
6.18 ZodelBiotec Ltd.
6.18.1 ZodelBiotec Ltd. Corporation Information
6.18.2 ZodelBiotec Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Description and Business Overview
6.18.3 ZodelBiotec Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales, Revenue and Gross Margin (2018-2024)
6.18.4 ZodelBiotec Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product Portfolio
6.18.5 ZodelBiotec Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Industry Chain Analysis
7.2 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Mode & Process
7.4 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales and Marketing
7.4.1 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Channels
7.4.2 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Distributors
7.5 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Customers
8 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Dynamics
8.1 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Industry Trends
8.2 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Drivers
8.3 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Challenges
8.4 Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Competitive Situation by Manufacturers in 2022
Table 4. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Kidney Injury Molecule 1 (KIM-1) ELISA Kit Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Kidney Injury Molecule 1 (KIM-1) ELISA Kit, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Kidney Injury Molecule 1 (KIM-1) ELISA Kit, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Kidney Injury Molecule 1 (KIM-1) ELISA Kit, Product Type & Application
Table 12. Global Key Manufacturers of Kidney Injury Molecule 1 (KIM-1) ELISA Kit, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Injury Molecule 1 (KIM-1) ELISA Kit as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Region (2018-2024) & (K Units)
Table 18. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Market Share by Region (2018-2024)
Table 19. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Region (2024-2029) & (K Units)
Table 20. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Market Share by Region (2024-2029)
Table 21. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Market Share by Region (2018-2024)
Table 23. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Market Share by Region (2024-2029)
Table 25. North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Country (2018-2024) & (K Units)
Table 27. North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Country (2024-2029) & (K Units)
Table 28. North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Country (2018-2024) & (K Units)
Table 32. Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Country (2024-2029) & (K Units)
Table 33. Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (K Units) by Type (2018-2024)
Table 51. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (K Units) by Type (2024-2029)
Table 52. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Market Share by Type (2018-2024)
Table 53. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Market Share by Type (2024-2029)
Table 54. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Market Share by Type (2018-2024)
Table 57. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Market Share by Type (2024-2029)
Table 58. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Price (US$/Unit) by Type (2018-2024)
Table 59. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Price (US$/Unit) by Type (2024-2029)
Table 60. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (K Units) by Application (2018-2024)
Table 61. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (K Units) by Application (2024-2029)
Table 62. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Market Share by Application (2018-2024)
Table 63. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Market Share by Application (2024-2029)
Table 64. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Market Share by Application (2018-2024)
Table 67. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Market Share by Application (2024-2029)
Table 68. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Price (US$/Unit) by Application (2018-2024)
Table 69. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Price (US$/Unit) by Application (2024-2029)
Table 70. Elabscience Biotechnology Inc. Corporation Information
Table 71. Elabscience Biotechnology Inc. Description and Business Overview
Table 72. Elabscience Biotechnology Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Elabscience Biotechnology Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product
Table 74. Elabscience Biotechnology Inc. Recent Developments/Updates
Table 75. Crystal Chem Corporation Information
Table 76. Crystal Chem Description and Business Overview
Table 77. Crystal Chem Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Crystal Chem Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product
Table 79. Crystal Chem Recent Developments/Updates
Table 80. Wuhan Fine Biotech Co., Ltd. Corporation Information
Table 81. Wuhan Fine Biotech Co., Ltd. Description and Business Overview
Table 82. Wuhan Fine Biotech Co., Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Wuhan Fine Biotech Co., Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product
Table 84. Wuhan Fine Biotech Co., Ltd. Recent Developments/Updates
Table 85. MyBiosource, Inc. Corporation Information
Table 86. MyBiosource, Inc. Description and Business Overview
Table 87. MyBiosource, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. MyBiosource, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product
Table 89. MyBiosource, Inc. Recent Developments/Updates
Table 90. Shanghai Korain Biotech Co., Ltd. Corporation Information
Table 91. Shanghai Korain Biotech Co., Ltd. Description and Business Overview
Table 92. Shanghai Korain Biotech Co., Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Shanghai Korain Biotech Co., Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product
Table 94. Shanghai Korain Biotech Co., Ltd. Recent Developments/Updates
Table 95. Abcam Corporation Information
Table 96. Abcam Description and Business Overview
Table 97. Abcam Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Abcam Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product
Table 99. Abcam Recent Developments/Updates
Table 100. Enzo Life Sciences, Inc. Corporation Information
Table 101. Enzo Life Sciences, Inc. Description and Business Overview
Table 102. Enzo Life Sciences, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Enzo Life Sciences, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product
Table 104. Enzo Life Sciences, Inc. Recent Developments/Updates
Table 105. CUSABIO Corporation Information
Table 106. CUSABIO Description and Business Overview
Table 107. CUSABIO Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. CUSABIO Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product
Table 109. CUSABIO Recent Developments/Updates
Table 110. CLOUD-CLONE CORP. Corporation Information
Table 111. CLOUD-CLONE CORP. Description and Business Overview
Table 112. CLOUD-CLONE CORP. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. CLOUD-CLONE CORP. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product
Table 114. CLOUD-CLONE CORP. Recent Developments/Updates
Table 115. Creative Diagnostics Corporation Information
Table 116. Creative Diagnostics Description and Business Overview
Table 117. Creative Diagnostics Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Creative Diagnostics Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product
Table 119. Creative Diagnostics Recent Developments/Updates
Table 120. Bio-Techne Corporation Information
Table 121. Bio-Techne Description and Business Overview
Table 122. Bio-Techne Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Bio-Techne Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product
Table 124. Bio-Techne Recent Developments/Updates
Table 125. Innovative Research Corporation Information
Table 126. Innovative Research Description and Business Overview
Table 127. Innovative Research Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Innovative Research Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product
Table 129. Innovative Research Recent Developments/Updates
Table 130. RayBiotech, Inc. Corporation Information
Table 131. RayBiotech, Inc. Description and Business Overview
Table 132. RayBiotech, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. RayBiotech, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product
Table 134. RayBiotech, Inc. Recent Developments/Updates
Table 135. Assay Genie Corporation Information
Table 136. Assay Genie Description and Business Overview
Table 137. Assay Genie Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Assay Genie Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product
Table 139. Assay Genie Recent Developments/Updates
Table 140. Cepham Life Sciences, Inc Corporation Information
Table 141. Cepham Life Sciences, Inc Description and Business Overview
Table 142. Cepham Life Sciences, Inc Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Cepham Life Sciences, Inc Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product
Table 144. Cepham Life Sciences, Inc Recent Developments/Updates
Table 145. Abbexa Corporation Information
Table 146. Abbexa Description and Business Overview
Table 147. Abbexa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Abbexa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product
Table 149. Abbexa Recent Developments/Updates
Table 150. Geno Technology, Inc. Corporation Information
Table 151. Geno Technology, Inc. Description and Business Overview
Table 152. Geno Technology, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. Geno Technology, Inc. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product
Table 154. Geno Technology, Inc. Recent Developments/Updates
Table 155. ZodelBiotec Ltd. Corporation Information
Table 156. ZodelBiotec Ltd. Description and Business Overview
Table 157. ZodelBiotec Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 158. ZodelBiotec Ltd. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Product
Table 159. ZodelBiotec Ltd. Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Distributors List
Table 163. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Customers List
Table 164. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Trends
Table 165. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Drivers
Table 166. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Challenges
Table 167. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Kidney Injury Molecule 1 (KIM-1) ELISA Kit
Figure 2. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Share by Type in 2022 & 2029
Figure 4. Human Product Picture
Figure 5. Mouse Product Picture
Figure 6. Rat Product Picture
Figure 7. Porcine Product Picture
Figure 8. Others Product Picture
Figure 9. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 10. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Share by Application in 2022 & 2029
Figure 11. Hospital
Figure 12. Research Institute
Figure 13. Others
Figure 14. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Size (2018-2029) & (US$ Million)
Figure 16. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales (2018-2029) & (K Units)
Figure 17. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Average Price (US$/Unit) & (2018-2029)
Figure 18. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Report Years Considered
Figure 19. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Share by Manufacturers in 2022
Figure 20. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest Kidney Injury Molecule 1 (KIM-1) ELISA Kit Players: Market Share by Revenue in 2022
Figure 22. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 23. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 24. North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Market Share by Country (2018-2029)
Figure 25. North America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Market Share by Country (2018-2029)
Figure 26. United States Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Canada Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Market Share by Country (2018-2029)
Figure 29. Europe Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Market Share by Country (2018-2029)
Figure 30. Germany Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Market Share by Region (2018-2029)
Figure 36. Asia Pacific Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Market Share by Region (2018-2029)
Figure 37. China Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Japan Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. South Korea Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. India Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Australia Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. China Taiwan Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Market Share by Country (2018-2029)
Figure 45. Latin America Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. UAE Kidney Injury Molecule 1 (KIM-1) ELISA Kit Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Kidney Injury Molecule 1 (KIM-1) ELISA Kit by Type (2018-2029)
Figure 55. Global Revenue Market Share of Kidney Injury Molecule 1 (KIM-1) ELISA Kit by Type (2018-2029)
Figure 56. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Price (US$/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of Kidney Injury Molecule 1 (KIM-1) ELISA Kit by Application (2018-2029)
Figure 58. Global Revenue Market Share of Kidney Injury Molecule 1 (KIM-1) ELISA Kit by Application (2018-2029)
Figure 59. Global Kidney Injury Molecule 1 (KIM-1) ELISA Kit Price (US$/Unit) by Application (2018-2029)
Figure 60. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Value Chain
Figure 61. Kidney Injury Molecule 1 (KIM-1) ELISA Kit Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed